Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP)

The Coronavirus Disease 2019 (COVID-19) pandemic curtailed clinical trial activity. Decentralized clinical trials (DCTs) can expand trial access and reduce exposure risk but their feasibility remains uncertain. We evaluated DCT feasibility for atrial fibrillation (AF) patients on oral anticoagulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarraju, Ashish, Seninger, Clark, Parameswaran, Vijaya, Petlura, Christina, Bazouzi, Tamara, Josan, Kiranbir, Grewal, Upinder, Viethen, Thomas, Mundl, Hardi, Luithle, Joachim, Basobas, Leonard, Touros, Alexis, Senior, Michael J. T., De Lombaert, Koen, Mahaffey, Kenneth W., Turakhia, Mintu P., Dash, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240050/
https://www.ncbi.nlm.nih.gov/pubmed/35764796
http://dx.doi.org/10.1038/s41746-022-00622-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240050/
https://www.ncbi.nlm.nih.gov/pubmed/35764796
http://dx.doi.org/10.1038/s41746-022-00622-9

Ejemplares similares